Is altimmune stock a buy
Web14 apr. 2024 · The stock is rated as a Hold by 1 analyst(s), 7 recommend it as a Buy and 0 called the ALT stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is … WebAltimmune (ALT) Receives a Buy from B.Riley Financial Mar. 21, 2024 at 12:05 p.m. ET on TipRanks.com Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and …
Is altimmune stock a buy
Did you know?
Web11 nov. 2024 · It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners... Web8 apr. 2024 · According to the issued ratings of 8 analysts in the last year, the consensus rating for Altimmune stock is Moderate Buy based on the current 1 hold rating and …
WebYou can buy and sell Altimmune (ALT) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other … Web31 mrt. 2024 · Step 1: Choose where to buy Altimmune stock. You need a brokerage account to access the NASDAQ market and buy ALT stock. A brokerage account is an …
Web11 mei 2024 · Altimmune stock is now considered extended and out of buy range after clearing a 4.55 buy point in a first-stage consolidation. See if the stock forms a new pattern or follow-on buying... Web20 mrt. 2024 · What is the target price for Altimmune (ALT) stock? The latest price target for Altimmune ( NASDAQ: ALT) was reported by HC Wainwright & Co. on Thursday, March 9, 2024. The analyst firm set a ...
Web17 sep. 2024 · Our data indicates that Altimmune, Inc. has a market capitalization of US$649m, and total annual CEO compensation was reported as US$1.4m for the year to December 2024. We note that's an increase...
Web14 apr. 2024 · Altimmune Inc. (ALT) stock is currently valued at $4.61. During the last session, the stock experienced a remarkable rise, reaching $4.73 after opening at $4.11. The stock briefly dropped to $4.0709 before ultimately closing at $4.11. Top 5 EV Tech Stocks to Buy for 2024 melectronics applenarrow adhesive tapeWeb1 dag geleden · Altimmune, Inc. is a clinical-stage biopharmaceutical company that is focused on developing treatments for obesity and liver diseases. The Company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and … narrow adjustable shelvesWeb27 okt. 2024 · Is Altimmune stock a good buy now? Since closing price on 2024-04-06 is $4.01000022888184 and forecast for 2024 Apr. is $2.53, Altimmune stock is not a good 1 year investment. 14 Days Historical Data for Altimmune stock price. Date Close Open Low ... narrow acoustic guitar gibsonWeb11 apr. 2024 · Should you invest in Altimmune (Nasdaq:ALT)? Flawless balance sheet and slightly overvalued. Home Markets Discover Watchlist Portfolios Screener. Stocks / ... changes and price drops for Altimmune; Historical stock prices; Current Share Price: US$4.14: 52 Week High: US$23.49: 52 Week Low: US$3.82: Beta-0.096: 1 Month … melectronic fernseherWeb11 apr. 2024 · Harris Matthew Scott, the Chief Medical Officer of Altimmune Inc., purchase 10,000 shares at $4.22 during a trade that took place back on Mar 23, which means that Harris Matthew Scott is holding 33,311 shares at $42,200 based on the most recent closing price. Stock Fundamentals for ALT narrow airway icd 10Web21 mrt. 2024 · Altimmune (ALT) Receives a Buy from B.Riley Financial TipRanks Mar. 21, 2024, 11:05 AM In a report released today, Mayank Mamtani from B.Riley Financial … melectronics bamix